We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

152 hedge funds and large institutions have $796M invested in Dr. Reddy's Laboratories in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,691% more call options, than puts

Call options by funds: $394K | Put options by funds: $22K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

1% more funds holding

Funds holding: 150 → 152 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $812M → $796M (-$16.1M)

4% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 53

2.03% less ownership

Funds ownership: 65.23% → 63.2% (-2%)

Holders
152
Holders Change
+2
Holders Change %
+1.33%
% of All Funds
3.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
51
Reduced
53
Closed
16
Calls
$394K
Puts
$22K
Net Calls
+$372K
Net Calls Change
+$342K

Top Buyers

Rank Fund Capital Flow
1
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking
Japan
+$15.9M
2
Goldman Sachs
Goldman Sachs
New York
+$10.9M
3
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M
4
Marshall Wace
Marshall Wace
United Kingdom
+$5.42M
5
MWNA
Marshall Wace North America
New York
+$5.32M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$9.2M
2
Swiss National Bank
Swiss National Bank
Switzerland
-$5.31M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.79M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4.63M
5
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
-$3.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
101
Point72 Asset Management
Connecticut
$296K +$291K +39,100 New
HC
102
Henshaw Capital
Massachusetts
$275K – – –
Aviva
103
Aviva
United Kingdom
$264K -$818 -110 -0.3%
Creative Planning
104
Creative Planning
Kansas
$247K +$7.59K +1,020 +3%
WS
105
Wedbush Securities
California
$233K +$409 +55 +0.2%
PP
106
Paloma Partners
Connecticut
$224K +$220K +29,585 New
QI
107
QS Investors
New York
$214K – – –
MIFH
108
Migdal Insurance & Financial Holdings
Israel
$205K – – –
PP
109
Prudential plc
United Kingdom
$205K – – –
FIM
110
Freedom Investment Management
Connecticut
$204K +$335 +45 +0.2%
TC
111
TownSquare Capital
Utah
$203K +$187K +25,180 New
Jane Street
112
Jane Street
New York
$200K -$87.5K -11,765 -31%
S
113
SignatureFD
Georgia
$193K +$45.5K +6,115 +32%
AG
114
Advisor Group
Arizona
$145K +$4.31K +580 +3%
PNC Financial Services Group
115
PNC Financial Services Group
Pennsylvania
$141K -$29.3K -3,935 -17%
Russell Investments Group
116
Russell Investments Group
United Kingdom
$119K -$257K -34,500 -69%
NIT
117
NumerixS Investment Technologies
British Columbia, Canada
$83K – – –
PA
118
Parallel Advisors
California
$68K +$19.7K +2,650 +41%
CSS
119
Cubist Systematic Strategies
Connecticut
$61K -$390K -52,475 -87%
LC
120
Lindbrook Capital
California
$59K +$4.05K +545 +8%
Mitsubishi UFJ Asset Management
121
Mitsubishi UFJ Asset Management
Japan
$46K +$9.67K +1,300 +27%
CAW
122
Cornerstone Advisors (Washington)
Washington
$40K +$6.99K +940 +22%
QCIG
123
Quad-Cities Investment Group
Iowa
$38K – – –
Carson Wealth (CWM LLC)
124
Carson Wealth (CWM LLC)
Nebraska
$36K – – –
GKIM
125
GW&K Investment Management
Massachusetts
$34K +$33.7K +4,525 New
3 4
5
6 7

RDY Hedge Fund Activity: Q3 2019 in Review

152 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2019, worth a combined $796M — down 2% from $812M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RDY positions and 16 closed out — a net gain of 2 holders — while 51 added to existing stakes and 53 trimmed.

The largest buyer was Mitsubishi UFJ Trust & Banking, adding an estimated $15.9M. The largest seller was BlackRock, cutting an estimated $9.2M.

  • 152 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2019, up from 150 in Q2 2019.
  • Funds reported $796M of Dr. Reddy's Laboratories stock for Q3 2019, down 2% quarter-over-quarter.
  • 18 funds opened new Dr. Reddy's Laboratories positions in Q3 2019 and 16 closed out, a net change of +2 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2019 was Mitsubishi UFJ Trust & Banking, an estimated $15.9M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2019 was BlackRock, an estimated $9.2M sold.

Based on aggregated 13F filings for Q3 2019.